全球肺功能檢測系統市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

肺功能測試系統市場預計將從 2025 年的 36.3 億美元成長到 2034 年的 67.1 億美元，預計從 2026 年到 2034 年將以 7.07% 的複合年成長率成長。

全球肺功能檢測系統市場穩定成長，主要受氣喘、慢性阻塞性肺病（COPD）和肺部感染疾病等呼吸道疾病日益普遍的推動。醫療專業人員越來越依賴肺功能檢測來評估肺活量、氣流和整體呼吸健康狀況。診斷設備的科技進步和數位化監控工具的整合提高了這些系統的準確性和效率。人們對疾病早期檢測意識的提高以及對醫療基礎設施投入的增加也促進了市場擴張。

推動此市場成長的關鍵因素包括：吸菸相關肺部疾病發生率的上升以及老年人口的成長，這些因素共同推動了呼吸系統診斷的需求。醫院和診斷檢查室正在採用具備自動化數據分析和攜帶式檢測功能的先進檢測系統。此外，日益嚴重的空氣污染以及職業性有害顆粒物暴露，也增加了定期進行呼吸系統健康評估的必要性，從而進一步促進了肺功能檢測設備的普及。

在創新和醫療服務覆蓋範圍不斷擴大的推動下，市場預計將持續成長。隨著遠端患者監護的普及，攜帶式和家用肺功能檢測設備有望得到更廣泛的應用。與數位健康平台和人工智慧的整合有望提高診斷準確性和患者管理水平。在新興經濟體，隨著醫療體系的現代化以及各國政府加大對呼吸系統疾病篩檢和預防醫學的投入，預計將湧現龐大的商機。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球肺功能測試系統市場：依產品分類

• 市場分析、洞察與預測
• 攜帶式的
• 桌面型

第5章 全球肺功能檢測系統市場：依檢測類型分類

• 市場分析、洞察與預測
• 肺功能測定
• 運動壓力測試
• 肺容量測試
• 高空模擬試驗
• 氣體擴散法
• 其他測試類型

第6章 全球肺功能測試系統市場：依應用分類

• 市場分析、洞察與預測
• 慢性阻塞性肺病
• 氣喘
• 慢性呼吸困難
• 肺纖維化
• 其他用途

第7章 全球肺功能測試系統市場：依最終用途分類

• 市場分析、洞察與預測
• 醫院和診所
• 診斷中心
• 居家醫療環境
• 其他最終用戶

第8章 全球肺功能檢測系統市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第9章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第10章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Baxter International Inc
  • Chest MI Inc
  • COSMED Srl
  • ECO Medics AG
  • Fukuda Sangyo Co. Ltd
  • Ganshorn Medizin Electronic GmbH（Schiller Group）
  • Geratherm Respiratory GmbH
  • Medical Equipment Europe GmbH
  • MGC Diagnostics Corporation
  • Minato Medical Science Co. Ltd
  • Morgan Scientific Inc

The Pulmonary Function Testing Systems Market size is expected to reach USD 6.71 Billion in 2034 from USD 3.63 Billion (2025) growing at a CAGR of 7.07% during 2026-2034.

The global pulmonary function testing systems market has grown steadily due to the rising prevalence of respiratory diseases such as asthma, chronic obstructive pulmonary disease, and lung infections. Healthcare providers increasingly rely on pulmonary function tests to assess lung capacity, airflow, and overall respiratory health. Technological advancements in diagnostic equipment and the integration of digital monitoring tools have improved the accuracy and efficiency of these systems. Growing awareness about early disease detection and increasing healthcare infrastructure investments have also supported the market's expansion.

Several key drivers are fueling the growth of this market. The increasing incidence of smoking-related lung disorders and the growing geriatric population have created greater demand for respiratory diagnostics. Hospitals and diagnostic laboratories are adopting advanced testing systems that offer automated data analysis and portable testing capabilities. In addition, rising air pollution levels and occupational exposure to harmful particles have increased the need for routine respiratory health assessments, further encouraging the adoption of pulmonary function testing equipment.

Looking ahead, the market is expected to experience continued growth driven by innovation and expanding healthcare access. Portable and home-based pulmonary testing devices are likely to gain popularity as remote patient monitoring becomes more common. Integration with digital health platforms and artificial intelligence may enhance diagnostic accuracy and patient management. Emerging economies are expected to offer significant opportunities as healthcare systems modernize and governments invest more heavily in respiratory disease screening and preventive care.

MARKET SEGMENTATION

By Product

• Handheld
• Tabletop

By Test Type

• Spirometry
• Exercise Stress Test
• Lung Volume Test
• High Altitude Simulation Testing
• Gas Diffusion Test
• Other Test Types

By Application

• Chronic Obstructive Pulmonary Disease
• Asthma
• Chronic Shortness of Breath
• Pulmonary Fibrosis
• Other Applications

By End Use

• Hospitals & Clinics
• Diagnostic Centers
• Homecare Settings
• Other End Users

COMPANIES PROFILED

• Baxter International Inc, Chest MI Inc, COSMED Srl, ECO Medics AG, Fukuda Sangyo Co Ltd, Ganshorn Medizin Electronic GmbH Schiller Group, Geratherm Respiratory GmbH, Medical Equipment Europe GmbH, MGC Diagnostics Corporation, Minato Medical Science Co Ltd, Morgan Scientific Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL PULMONARY FUNCTION TESTING SYSTEMS MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Handheld Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Tabletop Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL PULMONARY FUNCTION TESTING SYSTEMS MARKET: BY TEST TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Test Type
• 5.2. Spirometry Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Exercise Stress Test Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Lung Volume Test Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. High Altitude Simulation Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Gas Diffusion Test Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Other Test Types Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL PULMONARY FUNCTION TESTING SYSTEMS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Application
• 6.2. Chronic Obstructive Pulmonary Disease Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Asthma Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Chronic Shortness of Breath Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Pulmonary Fibrosis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Other Applications Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL PULMONARY FUNCTION TESTING SYSTEMS MARKET: BY END USE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End Use
• 7.2. Hospitals & Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Diagnostic Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Homecare Settings Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Other End Users Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL PULMONARY FUNCTION TESTING SYSTEMS MARKET: BY REGION 2022-2034 (USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Product
  • 8.2.2 By Test Type
  • 8.2.3 By Application
  • 8.2.4 By End Use
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Product
  • 8.3.2 By Test Type
  • 8.3.3 By Application
  • 8.3.4 By End Use
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Product
  • 8.4.2 By Test Type
  • 8.4.3 By Application
  • 8.4.4 By End Use
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Product
  • 8.5.2 By Test Type
  • 8.5.3 By Application
  • 8.5.4 By End Use
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Product
  • 8.6.2 By Test Type
  • 8.6.3 By Application
  • 8.6.4 By End Use
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL PULMONARY FUNCTION TESTING SYSTEMS INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Baxter International Inc
  • 10.2.2 Chest M.I. Inc
  • 10.2.3 COSMED Srl
  • 10.2.4 ECO Medics AG
  • 10.2.5 Fukuda Sangyo Co. Ltd
  • 10.2.6 Ganshorn Medizin Electronic GmbH (Schiller Group)
  • 10.2.7 Geratherm Respiratory GmbH
  • 10.2.8 Medical Equipment Europe GmbH
  • 10.2.9 MGC Diagnostics Corporation
  • 10.2.10 Minato Medical Science Co. Ltd
  • 10.2.11 Morgan Scientific Inc